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New biomarkers can improve the early detection of bone pathology (i.e.: osteonecrosis, osteomyelitis). We recruited 26 patients with a new diagnosis of radiolucent lesions of mandibular and maxillary bone. In adults, the reference range 
of alpha-(1)-acid glycoprotein is 0.4-1.0 AGP g/L (women), and 0.6-1.2 AGP g/L (men). A value at or above 0.70 grams 
per liter of orosomucoid was the best cutoff for assessing possible “low-grade” osteonecrosis, osteomyelitis in patients with 
inflammation of the bone. Mercury, palladium, and titanium were the most common metals associated with bone pathology. 
In 26 individuals with bone pathology associated with odontogenic infections, the mean (±SD) level of alpha-1-glycoprotein 
acid was 0.76 (±0.23) grams per liter (g/L). In four patients with no clinically visible radiolucent lesions, there was a decline in 
the mean level of alpha-1-glycoprotein acid was 0.64 (±0.12) grams per liter (g/L). Serum marker of inflammation – alpha 1 
glycoprotein acid – is associated with the development of bone inflammation arising from odontogenic structures in patients 
with adverse events to metals.
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